Abstract
About 6000 women in the United Kingdom develop ovarian cancer each year and about two-thirds of the women will die from the disease. Establishing the prognosis of a woman with ovarian cancer is an important part of her evaluation and treatment. Prognostic models and indices in ovarian cancer should be developed using large databases and, ideally, with complete information on both prognostic indicators and long-term outcome. We developed a prognostic model using Cox regression and multiple imputation from 1189 primary cases of epithelial ovarian cancer (with median follow-up of 4.6 years). We found that the significant (P≤ 0.05) prognostic factors for overall survival were age at diagnosis, FIGO stage, grade of tumour, histology (mixed mesodermal, clear cell and endometrioid versus serous papillary), the presence or absence of ascites, albumin, alkaline phosphatase, performance status on the ZUBROD-ECOG-WHO scale, and debulking of the tumour. This model is consistent with other models in the ovarian cancer literature; it has better predictive ability and, after simplification and validation, could be used in clinical practice. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Alberts DS, Dahlberg S and Green SJ (1993) Analysis of patient age as an independent prognostic factor for survival in a Phase III study of cisplatin-cyclophosphamide versus carboplatin cyclophosphamide in Stages III and IV ovarian cancer. Cancer 71: 618–627
Altman DG and Royston P (2000) What do we mean by validating a prognostic model?. Stat Med 19: 453–473
Ansell SM, Rappoport BL and Falkson G (1993) Survival determinants in patients with advanced ovarian cancer. Gynecol Oncol 30: 215–220
Brinkhuis M, Baak JPA and Meijer GA (1996) Value of quantitative pathological variables as prognostic factors in advanced ovarian carcinoma. J Clin Pathol 49: 142–148
Brun J, Feyler A and Chene G (2000) Long-term results and prognostic factors in patients with epithelial cancer. Gynecol Oncol 78: 21–27
Bruzzone M, Gadduci A and Brunetti I (1995) Prognostic factors affecting long-term survival of advanced ovarian cancer patients: univariate and multivariate analysis at 12 years of follow-up. Proc Am Soc Clin Oncol 14: 812
Carey MS, Dembo AJ and Simm JE (1993) Testing the validity of a prognostic classification in patients with surgically optimal ovarian cancer: a 15 year review. Int J Gynecol Cancer 3: 24–35
CRC CancerStats (2000) http://www.crc.org.uk/cancer/cancer_intro.html, Cancer Research Campaign
Dembo AJ, Bush RS and Brown TC (1982) Clinico-pathological correlates in ovarian cancer. Bull Cancer 69: 292–297
Eisenhauer EA, Gore M and Neijt JP (1999) Ovarian cancer: should we be managing patients with good and bad prognostic factors in the same manner?. Annals of Oncology 10: S9–S15
Gelfand AE and Smith AFM (1990) Sampling-based approaches to calculating marginal densities. J Am Stat Assoc 85: 398–409
Grambsch P and Therneau T (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81: 515–526
Greenland S and Finkle WD (1995) A critical look at methods of handling missing covariates in epidemiologic regression analysis. Am J Epi 142: 1255–1264
Harrell FE (1996) Multivariate prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15: 361–387
Hartmann LC, Podratz KC and Kleeney GL (1994) Prognostic significance of p53 immunostaining in epithelial ovarian cancer. J Clin Oncol 12: 64–69
Hogberg T, Cartensen J and Simonsen E (1993) Treatment results and prognostic factors in a population-based study of epithelial ovarian cancer. Gynecol Oncol 48: 38–49
Hosmer DW and Lemeshow S . Applied Survival Analysis: Regression modeling of time to event data, Wiley: New York, 1999
Junor EJ, Hole DJ and McNulty L (1999) Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br J Obstet Gynaecol 106: 1130–1136
Kappen HJ and Neijt JP (1993) Neural network analysis to predict treatment outcome. Ann Oncol 4: 31–34
Kehoe S, Powell J and Wilson S (1994) The influence of operating surgeon's specialisation on patient survival in ovarian carcinoma. Br J Cancer 70: 1015–1017
Kosary CL (1994) FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973–87 SEER cases of cancers of the endometrium, cervix, ovary, vulva and vagina. Sem Surg Oncol 10: 31–46
Lubsen J, Pool J and van der Does E (1978) A practical device for the application of a diagnostic or prognostic function. Meth Inform Med 17: 127–129
Lund B and Williamson P (1991) Prognostic factors for overall survival in patients with advanced ovarian carcinoma. Ann Oncol 2: 281–287
Lund B, Williamson P, van Houwelingen HC and Neijt JP (1990) Comparison of the predictive power of different prognostic indices for overall survival in patients with advanced ovarian carcinoma. Cancer Research 50: 4626–4269
Makar AP, Baekelandt M and Trope CG (1995) The prognostic significance of residual disease, FIGO substage, tumor histology and grade in patients with FIGO stage III ovarian cancer. Gynecol Oncol 56: 175–180
Marsoni S, Torri V and Valsecchi MG (1990) Prognostic factors in advanced epithelial ovarian cancer. Br J Cancer 62: 444–450
Marx D, Meden H and Brune T (1997) Mib-1 evaluated proliferative activity in ovarian cancer with respect to prognostic significance. Anticancer Research 17: 775–180
Meden H, Marx D and Raab T (1995) EGF-R and overexpression of the oncogene c-erbB-2 in ovarian cancer: immunohistochemical findings and prognostic value. J Obstet Gynecol 21: 167–178
Nagele F, Petru E and Medl M (1995) Preoperative CA125: an independent prognostic factor in patients with stage I epithelial ovarian cancer. Obstet Gynecol 86: 259–264
Peters-Engl C, Obermair A and Heinzl H (1999) CA125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer. Br J Cancer 81: 662–666
Royston P and Altman DG (1994) Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. Appl Statist 43: 429–467
Rubin DB (1987) Multiple Imputation for Nonresponse in Surveys. Wiley: New York
Simon R and Altman DG (1994) Statistical aspects of prognostic factor studies in oncology. Br J Cancer 69: 979–985
Swenerton KD, Hislop TG and Spinelli J (1985) Ovarian carcinoma: A multivariate analysis of prognostic factors. Obstet Gynecol 65: 264–269
Van Buuren S, Boshuizen HC and Knook DL (1999) Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 18: 681–694
Van Houwelingen JC, Ten Bokkel Huinink WW and Van der Burg ATM (1989) Predictability of the survival of patients with ovarian cancer. J Clin Oncol 7: 769–763
Warwick J, Kehoe S and Earl H (1995) Long-term follow-up of patients with advanced ovarian cancer treated in randomised trials. Br J Cancer 72: 1513–7
Wyatt JC and Altman DG (1995) Commentary: Prognostic models: clinically useful or quickly forgotten?. Br Med J 311: 1539–1541
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Clark, T., Stewart, M., Altman, D. et al. A prognostic model for ovarian cancer. Br J Cancer 85, 944–952 (2001). https://doi.org/10.1054/bjoc.2001.2030
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2030
Keywords
This article is cited by
-
Pre-operative plasma VEGF-C levels portend recurrence in epithelial ovarian cancer patients and is a bankable prognostic marker even in the initial assessment of a patient
Journal of Ovarian Research (2024)
-
Clinicopathological Nomogram for Predicting Platinum-Resistant/Refractory Epithelial Ovarian Cancer
Indian Journal of Gynecologic Oncology (2024)
-
Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer
British Journal of Cancer (2022)
-
Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: the PREDICT study
BMC Cancer (2021)
-
Recent Advances and Future Directions of Diagnostic and Prognostic Prediction Models in Ovarian Cancer
Journal of Shanghai Jiaotong University (Science) (2021)